ID   AP7P
AC   CVCL_J287
SY   AP07P
DR   BioSample; SAMN03472407
DR   JCRB; JCRB3011
DR   JCRB; KURB1401
DR   Wikidata; Q54750300
RX   DOI=10.1007/0-387-33776-8_11;
RX   PubMed=10090479;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.2152_2778del (Ex24-28del); Zygosity=Heterozygous (DOI=10.1007/0-387-33776-8_11; PubMed=10090479).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser849Phefs*40 (c.2546delC); ClinVar=VCV000408166; Zygosity=Heterozygous (DOI=10.1007/0-387-33776-8_11; PubMed=10090479).
CC   Discontinued: JCRB; KURB1401; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3011
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D5S818: 10
ST   D7S820: 10,12
ST   TH01: 9,10
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
RX   DOI=10.1007/0-387-33776-8_11;
RA   Tachibana A.;
RT   "Mutational analyses of Fanconi anemia genes in Japanese patients.";
RL   (In book chapter) Molecular mechanisms of Fanconi anemia; Ahmad S.I., Kirk S.H. (eds.); pp.103-114; Springer; New York; USA (2006).
//
RX   PubMed=10090479; DOI=10.1002/(SICI)1098-1004(1999)13:3<237::AID-HUMU8>3.0.CO;2-F;
RA   Tachibana A., Kato T., Ejima Y., Yamada T., Shimizu T., Yang L.-C.,
RA   Tsunematsu Y., Sasaki M.S.;
RT   "The FANCA gene in Japanese Fanconi anemia: reports of eight novel
RT   mutations and analysis of sequence variability.";
RL   Hum. Mutat. 13:237-244(1999).
//